FDA Staff Reviewers Cast Doubt on Safety and Efficacy of Popular Peptides, Contrasting with Health Chief’s Advocacy

Washington D.C. – A significant divergence has emerged between the findings of U.S. Food and Drug Administration (FDA) staff reviewers and the public pronouncements of Health Secretary Robert F. Kennedy,…

SoftBank CEO Masayoshi Son Casts Doubt on Elon Musk’s Orbital Data Center Vision Amidst Accelerating AI Race

In a significant challenge to one of the tech world’s most ambitious proposals, Masayoshi Son, the founder and CEO of SoftBank, has publicly dismissed Elon Musk’s vision for orbital data…

A Major Cochrane Review Casts Doubt on the Efficacy and Safety of Amyloid-Targeting Alzheimer’s Drugs

A comprehensive analysis of 17 clinical trials involving over 20,000 participants has concluded that drugs designed to target amyloid beta proteins in the brain are unlikely to offer significant clinical…

The Promise and Peril of Anti-Amyloid Drugs for Alzheimer’s Disease: A Landmark Review Casts Doubt on Clinical Efficacy and Highlights Safety Concerns

A comprehensive and influential Cochrane review has delivered a significant blow to the long-held therapeutic strategy targeting amyloid beta proteins in the brain for Alzheimer’s disease, concluding that these drugs…

Reasoning does hurt: deliberation is associated with heightened levels of doubt

The human brain is a master of efficiency, often relying on rapid-fire intuitions to navigate the complexities of daily life. However, when these mental shortcuts lead to a potential error,…